Physician profile
Michael Cassella
NPI 1255941738
$1,917.71
in general payments reported to CMS, 2019-2025
21 companies · $806 in 2025
The $806 reported for 2025 was more than what 80% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $326 · 2023: $413 · 2024: $372 · 2025: $806.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,556 · Education: $36.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,555.91 |
| Education | $36.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $373.52 | 2022-2025 | Erleada |
| Abbvie INC. | $355.34 | 2022-2025 | |
| Medtronic, INC. | $258.72 | 2025 | Interstim |
| Antares Pharma, INC. | $98.58 | 2023-2025 | Xyosted, Tlando, Nocdurna |
| Endo Pharmaceuticals INC. | $96.75 | 2022-2024 | Xiaflex |
| Urogen Pharma, INC. | $86.40 | 2025 | |
| Endo USA, INC. | $82.63 | 2024-2025 | Xiaflex |
| Progenics Pharmaceuticals, INC. | $65.93 | 2024-2025 | |
| Boston Scientific Corporation | $63.11 | 2023-2025 | Accolade Sr, Spaceoar Vue System - 10ml |
| Sumitomo Pharma America, INC. | $58.74 | 2023 | Orgovyx, Gemtesa |
| Merck Sharp & Dohme LLC | $56.74 | 2022-2024 | Keytruda |
| Blue Earth Diagnostics | $52.30 | 2024-2025 | Posluma |
| Halozyme INC | $50.84 | 2023 | |
| Karl Storz Endoscopy-America | $40.00 | 2023 | |
| Ferring Pharmaceuticals INC. | $34.98 | 2024 | Adstiladrin |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| 180 Medical, INC. | $29.52 | 2023 | Cure Catheter |
| Astellas Pharma US INC | $27.47 | 2024 | Myrbetriq |
| Tolmar, INC. | $26.01 | 2023 | |
| Procept Biorobotics Corporation | $23.53 | 2025 | |
| Coloplast Corp | $18.65 | 2025 | |
| Tolmar Pharmaceuticals, INC. | $17.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Cassella listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.